Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Antidepressants in panic disorders.

M R Liebowitz¹

¹Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York.

The British Journal of Psychiatry. Supplement

|October 1, 1989

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder.

Psychological medicine·2010

Same author

Attachment in individuals with social anxiety disorder: the relationship among adult attachment styles, social anxiety, and depression.

Emotion (Washington, D.C.)·2003

Same author

Evaluation of the clinical global impression scale among individuals with social anxiety disorder.

Psychological medicine·2003

Same author

The psychometric properties of the Interpersonal Sensitivity Measure in social anxiety disorder.

Behaviour research and therapy·2002

Same author

Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder.

Depression and anxiety·2001

Same author

A controlled study of cognitive deficits in children with chronic Lyme disease.

The Journal of neuropsychiatry and clinical neurosciences·2001

Same journal

Economic evaluation of the anti-stigma social marketing campaign in England 2009-2011.

The British journal of psychiatry. Supplement·2013

Same journal

Anti-stigma training for medical students: the Education Not Discrimination project.

The British journal of psychiatry. Supplement·2013

Same journal

Influence of Time to Change's social marketing interventions on stigma in England 2009-2011.

The British journal of psychiatry. Supplement·2013

Same journal

Mental health problems in the workplace: changes in employers' knowledge, attitudes and practices in England 2006-2010.

The British journal of psychiatry. Supplement·2013

Same journal

Newspaper coverage of mental illness in England 2008-2011.

The British journal of psychiatry. Supplement·2013

Same journal

Experiences of discrimination among people using mental health services in England 2008-2011.

The British journal of psychiatry. Supplement·2013

See all related articles

Antidepressants have significantly advanced the understanding and treatment of panic disorders and anxiety. However, key questions about their therapeutic mechanisms, optimal treatment duration, and combination with cognitive behavioral therapy remain.

Area of Science:

Psychiatry
Pharmacology
Clinical Psychology

Background:

Antidepressant medications have profoundly influenced the understanding of anxiety disorders, including panic disorder.
This includes major impacts on classification, pathophysiology, and therapeutic strategies.

Purpose of the Study:

To highlight the significant impact of antidepressants on psychiatric practice and anxiety disorder treatment.
To identify unresolved issues in the field, guiding future research and clinical practice.

Main Methods:

The abstract does not specify methods, focusing on a review of existing knowledge and unresolved questions.

Main Results:

Antidepressants have demonstrably improved the understanding and management of panic and anxiety disorders.

Related Experiment Videos

Despite advances, significant questions persist regarding treatment mechanisms and optimal therapeutic approaches.

Conclusions:

While antidepressants are effective, further research is needed to elucidate their mechanisms of action.
Optimizing treatment duration and the integration of pharmacotherapy with cognitive behavioral treatments are critical for minimizing relapse and improving patient outcomes.